Endpoint’ers welcome Liz Troll as Vice President, Quality
Liz comes to Endpoint with a wealth of experience including senior leadership positions at esteemed biotech and CRO organizations, including Otsuka and Quintiles. With a background deeply rooted in all facets of systems design and implementation for GCP, GLP, and GMP compliance on a global scale, Liz brings invaluable expertise to the Endpoint team.
Her comprehensive understanding of measuring system effectiveness throughout the product development lifecycle aligns seamlessly with Endpoint’s commitment to excellence, and she possesses an exceptional ability to bridge the gap between customer needs and organizational capabilities, ensuring adherence to regulations while driving customer satisfaction.
Liz is not just your average quality pro – she has been on the frontline, actively involved in implementing new systems, revamping existing ones for compliance, and successfully defending systems design during regulatory inspections. With extensive experience in Quality across Sponsor, CRO, and consultant roles, she is poised to play a pivotal role in advancing Endpoint’s commitment to quality and innovation.
Please join us in extending a warm welcome to Liz as we embark on this exciting new chapter together at Endpoint!
Read more about Endpoint’s solutions at https://www.endpointclinical.com/solutions/